Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

In recent years, there has been an exponential increase in the generation and accessibility of electronic healthcare data, often referred to as “real-world data”. The landscape of data sources has significantly expanded to encompass traditional databases and newer sources such as the social media, w...

Descripció completa

Dades bibliogràfiques

Autors principals:	Salvatore Crisafulli, Francesco Ciccimarra, Chiara Bellitto, Massimo Carollo, Elena Carrara, Lisa Stagi, Roberto Triola, Annalisa Capuano, Cristiano Chiamulera, Ugo Moretti, Eugenio Santoro, Alberto Eugenio Tozzi, Giuseppe Recchia, Gianluca Trifirò
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-03-01
Col·lecció:	Frontiers in Drug Safety and Regulation
Matèries:	artificial intelligence machine learning pharmacological therapies pharmacovigilance pharmacoepidemiology real-world evidence
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fdsfr.2024.1356405/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!